BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,730 | -16.6% | 1,000 | 0.0% | 0.02% | -9.5% |
| Q2 2023 | $45,220 | +11.5% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $40,560 | -20.4% | 1,000 | 0.0% | 0.02% | -19.2% |
| Q4 2022 | $50,970 | -5.6% | 1,000 | 0.0% | 0.03% | -13.3% |
| Q3 2022 | $54,000 | -15.6% | 1,000 | 0.0% | 0.03% | -11.8% |
| Q2 2022 | $64,000 | -17.9% | 1,000 | 0.0% | 0.03% | -8.1% |
| Q1 2022 | $78,000 | -9.3% | 1,000 | 0.0% | 0.04% | -9.8% |
| Q4 2021 | $86,000 | +8.9% | 1,000 | 0.0% | 0.04% | +7.9% |
| Q3 2021 | $79,000 | -2.5% | 1,000 | 0.0% | 0.04% | -7.3% |
| Q2 2021 | $81,000 | -3.6% | 1,000 | 0.0% | 0.04% | -8.9% |
| Q1 2021 | $84,000 | +9.1% | 1,000 | 0.0% | 0.04% | -2.2% |
| Q4 2020 | $77,000 | -3.8% | 1,000 | 0.0% | 0.05% | -11.5% |
| Q3 2020 | $80,000 | -7.0% | 1,000 | 0.0% | 0.05% | -8.8% |
| Q2 2020 | $86,000 | +6.2% | 1,000 | 0.0% | 0.06% | -13.6% |
| Q1 2020 | $81,000 | -9.0% | 1,000 | 0.0% | 0.07% | +13.8% |
| Q4 2019 | $89,000 | +2.3% | 1,000 | 0.0% | 0.06% | -4.9% |
| Q3 2019 | $87,000 | +6.1% | 1,000 | 0.0% | 0.06% | +7.0% |
| Q2 2019 | $82,000 | +7.9% | 1,000 | 0.0% | 0.06% | +9.6% |
| Q1 2019 | $76,000 | +15.2% | 1,000 | 0.0% | 0.05% | +2.0% |
| Q4 2018 | $66,000 | +29.4% | 1,000 | +50.2% | 0.05% | +50.0% |
| Q3 2018 | $51,000 | +4.1% | 666 | 0.0% | 0.03% | -2.9% |
| Q2 2018 | $49,000 | +6.5% | 666 | 0.0% | 0.04% | +6.1% |
| Q1 2018 | $46,000 | +7.0% | 666 | -26.0% | 0.03% | +6.5% |
| Q3 2016 | $43,000 | +4.9% | 900 | 0.0% | 0.03% | +6.9% |
| Q2 2016 | $41,000 | +10.8% | 900 | 0.0% | 0.03% | +7.4% |
| Q1 2016 | $37,000 | +12.1% | 900 | 0.0% | 0.03% | +3.8% |
| Q4 2015 | $33,000 | +10.0% | 900 | 0.0% | 0.03% | +8.3% |
| Q3 2015 | $30,000 | -52.4% | 900 | 0.0% | 0.02% | -48.9% |
| Q2 2015 | $63,000 | -3.1% | 900 | -5.3% | 0.05% | -4.1% |
| Q1 2015 | $65,000 | -1.5% | 950 | +5.6% | 0.05% | 0.0% |
| Q4 2014 | $66,000 | +1.5% | 900 | 0.0% | 0.05% | 0.0% |
| Q3 2014 | $65,000 | 0.0% | 900 | 0.0% | 0.05% | -2.0% |
| Q2 2014 | $65,000 | -1.5% | 900 | 0.0% | 0.05% | -5.7% |
| Q1 2014 | $66,000 | +4.8% | 900 | 0.0% | 0.05% | +3.9% |
| Q4 2013 | $63,000 | +6.8% | 900 | 0.0% | 0.05% | -1.9% |
| Q3 2013 | $59,000 | -4.8% | 900 | 0.0% | 0.05% | -7.1% |
| Q2 2013 | $62,000 | – | 900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |